The random development of LOH on chromosome 9q in superficial bladder cancers

Journal of Pathology

Volumn 198, Issue 3, 2002, Pages 352-358

  Van Tilborg, Angela A G ^a   De Vries, Annie ^a   De Bont, Maarten ^a   Groenfeld, Lilian E ^a   Zwarthoff, Ellen C ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Bladder cancer; Chromosome 9q; Loss of heterozygosity; Tumour suppression gene

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RECURRENCE; CHROMOSOME 9Q; CHROMOSOME ARM; CHROMOSOME LOSS; CONTROLLED STUDY; GENE DELETION; GENE IDENTIFICATION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 9; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 0036840747     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1215     Document Type: Article

References (40)

1. Harris AL, Neal DE. Bladder cancer - field versus clonal origin. N Engl J Med 1992; 326: 759-761.
2. Louhelainen J, Wijkstrom H, Hemminki K. Allelic losses demonstrate monoclonality of multifocal bladder tumours. Int J Cancer 2000; 87: 522-527.
3. Sidransky D, Frost P, Von Eschenbach A, et al. Clonal origin of bladder cancer. N Engl J Med 1992; 326: 737-740.
4. Takahashi T, Habuchi T, Kakehi Y, et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 1998; 58: 5835-5841.
5. van Tilborg AA, de Vries A, de Bout M, et al. Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet 2000; 9: 2973-2980.
6. Poddighe PJ, Bringuier PP, Vallinga M, et al. Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. J Pathol 1996; 179: 169-176.
7. Pycha A, Mian C, Posch B, et al. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization. J Urol 1998; 160: 737-740.
8. Sauter G, Moch H, Carroll P, et al. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer 1995; 64: 99-103.
9. Kallioniemi A, Kallioniemi OP, Citro G, et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995; 12: 213-219.
10. Voorter C, Joos S, Vallinga M, et al. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 1995; 146: 1341-1354.
11. Cairns P, Shaw ME, Knowles MA. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene 1993; 8: 1083-1085.
12. Linnenbach AJ, Pressler LB, Seng BA, et al. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Hum Mol Genet 1993; 2: 1407-1411.
13. Cairns P, Shaw ME, Knowles MA. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 1993; 53: 1230-1232.
14. Keen AJ, Knowles MA. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 1994; 9: 2083-2088.
15. Devlin J, Keen AJ, Knowles MA. Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2 cM of IFN-A. Oncogene 1994; 9: 2757-2760.
16. Habuchi T, Devlin J, Elder PA, et al. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Oncogene 1995; 11: 1671-1674.
17. Habuchi T, Yoshida O, Knowles MA. A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Hum Mol Genet 1997; 6: 913-919.
18. Czerniak B, Li L, Chaturvedi V, et al. Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 2000; 27: 392-402.
19. van Tilborg AA, Groenfeld LE, van der Kwast TH, et al. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. Br J Cancer 1999; 80: 489-494.
20. van Tilborg AA, de Vries A, Zwarthoff EC. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer. J Pathol 2001; 194: 76-80.
21. Simoneau AR, Spruck CHr, Gonzalez-Zulueta M, et al. Evidence for two tumour suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res 1996; 56: 5039-5043.
22. Hornigold N, Devlin J, Davies AM, et al. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene 1999; 18: 2657-2661.
23. Habuchi T, Luscombe M, Elder PA, et al. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumour suppressor region at 9q32-q33. Genomics 1998; 48: 277-88.
24. Simoneau M, Aboulkassim TO, LaRue H, et al. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31. Oncogene 1999; 18: 157-163.
25. Knowles MA. Identification of novel bladder tumour suppressor genes. Electrophoresis 1999; 20: 269-279.
26. Czerniak B, Chaturvedi V, Li L, et al. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 1999; 18: 1185-1196.
27. Louhelainen J, Wijkstrorn H, Hemminki K. Initiation-development modelling of allelic losses on chromosome 9 in multifocal bladder cancer. Eur J Cancer 2000; 36: 1441-1451.
28. Ferguson DO, Sekiguchi JM, Chang S, et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci U S A 2000; 97: 6630-6633.
29. Latil A, Cussenot O, Fournier G, et al. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res 1997; 57: 1058-1062.
30. Papadimitrakopoulou VA, Oh Y, El-Naggar A, et al. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clin Cancer Res 1998; 4: 539-544.
31. Goldberg EK, Glendening JM, Karanjawala Z, et al. Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis. Am J Hum Genet 2000; 67: 417-431.
32. Maitra A, Wistuba II, Washington C, et al. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 2001; 159: 119-130.
33. Kirchweger R, Zeillinger R, Schneeberger C, et al. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer 1994; 56: 193-199.
34. Cleton-Jansen AM, Callen DF, Seshadri R, et al. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res 2001; 61: 1171-1177.
35. von Knobloch R, Bugert P, Jauch A, et al. Allelic changes at multiple regions of chromosome 5 are associated with progression of urinary bladder cancer. J Pathol 2000; 190: 163-168.
36. Louhelainen J, Wijkstrom H, Hemminki K. Multiple regions with allelic loss at chromosome 3 in superficial multifocal bladder tumors. Int J Oncol 2001; 18: 203-210.
37. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001; 61: 3230-3239.
38. Stoler DL, Chen N, Basik M, et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A 1999; 96: 15 121-15 126.
39. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
40. Hahn S, Schutte M, Hoque A, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353.